This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 and H1 FY27 revenue and profit surge
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 13.0 pts more than Nifty Microcap 250 and 12.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Resonance Specialties reported unaudited Q2 FY27 revenue of Rs 34.29 crore, up 59.2% from Rs 21.53 crore, and profit after tax of Rs 8.47 crore versus Rs 1.66 crore; EPS was Rs 7.33. H1 revenue rose 56.2% to Rs 66.87 crore and profit rose to Rs 14.21 crore from Rs 3.29 crore. Growth was export-led, with overseas revenue at Rs 49.31 crore versus Rs 22.75 crore.
Strong profit growth, export-led sales and positive operating cash flow support shareholders, but the high overseas revenue share is a risk.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹34.29 Cr | ₹21.53 Cr | +59.2% |
| Operating profit | ₹10.54 Cr | ₹1.97 Cr | +434.8% |
| Profit after tax | ₹8.47 Cr | ₹1.66 Cr | +411.0% |
| EBITDA margin | 31.8% | 11.0% | +20.8 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.